Aspirin and Cancer Risk, Semaglutide & Tirzepatide Trials, and Teen Mental Health Trends episode artwork

EPISODE · Aug 2, 2024 · 24 MIN

Aspirin and Cancer Risk, Semaglutide & Tirzepatide Trials, and Teen Mental Health Trends

from Morning Medical with Dr. Chow · host Chi-Ming Chow

In today's episode, Dr. Chi-Ming Chow discusses new research on aspirin use and its impact on colorectal cancer risk, alongside recent changes in guidelines. He then delves into the SELECT trial results concerning semaglutide and its effects on cardiovascular events, sharing expert views on the findings. The episode also covers the cardiovascular outcomes study of tirzepatide and its implications for Medicare coverage. Dr. Chow highlights teenage mental health trends, focusing on the impact of social media, and examines athlete sleep challenges, including the use of cardboard beds at the Paris 2024 Olympics. The episode concludes with a summary and sign-off.

Episode metadata supplied by the publisher feed · Published Aug 2, 2024

Embed this episode

Ready to play

Aspirin and Cancer Risk, Semaglutide & Tirzepatide Trials, and Teen Mental Health Trends

0:00 24:38

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Morning Medical with Dr. Chow?

This episode is 24 minutes long.

When was this Morning Medical with Dr. Chow episode published?

This episode was published on August 2, 2024.

Is there a transcript available for this episode?

Yes, a full transcript is available for this episode. You can read the complete transcript on the episode page.

Can I download this Morning Medical with Dr. Chow episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!